Keay Nakae
Stock Analyst at Chardan Capital
(3.92)
# 633
Out of 4,981 analysts
248
Total ratings
39.92%
Success rate
13.95%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNA Avidity Biosciences | Maintains: Buy | $75 | $44.74 | +67.64% | 19 | Sep 10, 2025 | |
| OBIO Orchestra BioMed Holdings | Maintains: Buy | $20 | $2.59 | +673.69% | 12 | Aug 13, 2025 | |
| KRRO Korro Bio | Maintains: Buy | $25 | $30.76 | -18.73% | 3 | Aug 13, 2025 | |
| MNPR Monopar Therapeutics | Maintains: Buy | $60 | $49.48 | +21.26% | 2 | Aug 13, 2025 | |
| COYA Coya Therapeutics | Maintains: Buy | $14 | $6.05 | +131.40% | 20 | Aug 13, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $60 | $29.72 | +101.88% | 20 | Aug 11, 2025 | |
| ABUS Arbutus Biopharma | Maintains: Buy | $5 | $4.46 | +12.11% | 13 | Aug 11, 2025 | |
| PRQR ProQR Therapeutics | Maintains: Buy | $4 | $2.19 | +82.65% | 15 | Aug 8, 2025 | |
| SABS SAB Biotherapeutics | Maintains: Buy | $20 → $12 | $2.12 | +466.04% | 16 | Aug 8, 2025 | |
| SLN Silence Therapeutics | Maintains: Buy | $35 | $4.51 | +676.05% | 13 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $400 | $465.89 | -14.14% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $38 | $13.14 | +189.30% | 13 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $0.93 | +435.62% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $1.25 → $6 | $15.91 | -62.29% | 10 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 | $5.90 | +238.98% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $1.66 | +261.45% | 7 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2.5 | $2.16 | +15.74% | 6 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $0.39 | +1,940.30% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.59 | - | 5 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $8 → $6 | $14.82 | -59.51% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $20 | $0.47 | +4,113.19% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $55 | $8.14 | +575.68% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.25 → $10 | $3.88 | +158.06% | 5 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $100 → $88 | $10.43 | +738.93% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $0.7 → $13 | $1.07 | +1,114.95% | 3 | Feb 9, 2021 |
Avidity Biosciences
Sep 10, 2025
Maintains: Buy
Price Target: $75
Current: $44.74
Upside: +67.64%
Orchestra BioMed Holdings
Aug 13, 2025
Maintains: Buy
Price Target: $20
Current: $2.59
Upside: +673.69%
Korro Bio
Aug 13, 2025
Maintains: Buy
Price Target: $25
Current: $30.76
Upside: -18.73%
Monopar Therapeutics
Aug 13, 2025
Maintains: Buy
Price Target: $60
Current: $49.48
Upside: +21.26%
Coya Therapeutics
Aug 13, 2025
Maintains: Buy
Price Target: $14
Current: $6.05
Upside: +131.40%
Arrowhead Pharmaceuticals
Aug 11, 2025
Maintains: Buy
Price Target: $60
Current: $29.72
Upside: +101.88%
Arbutus Biopharma
Aug 11, 2025
Maintains: Buy
Price Target: $5
Current: $4.46
Upside: +12.11%
ProQR Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $2.19
Upside: +82.65%
SAB Biotherapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $20 → $12
Current: $2.12
Upside: +466.04%
Silence Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $35
Current: $4.51
Upside: +676.05%
Aug 1, 2025
Maintains: Buy
Price Target: $325 → $400
Current: $465.89
Upside: -14.14%
Jul 29, 2025
Maintains: Buy
Price Target: $50 → $38
Current: $13.14
Upside: +189.30%
Jun 25, 2025
Maintains: Buy
Price Target: $5
Current: $0.93
Upside: +435.62%
May 8, 2025
Downgrades: Neutral
Price Target: $1.25 → $6
Current: $15.91
Upside: -62.29%
Apr 7, 2025
Maintains: Buy
Price Target: $20
Current: $5.90
Upside: +238.98%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $1.66
Upside: +261.45%
Mar 27, 2025
Maintains: Neutral
Price Target: $2.5
Current: $2.16
Upside: +15.74%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $0.39
Upside: +1,940.30%
Feb 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.59
Upside: -
Aug 4, 2023
Maintains: Sell
Price Target: $8 → $6
Current: $14.82
Upside: -59.51%
Nov 10, 2022
Maintains: Buy
Price Target: $60 → $20
Current: $0.47
Upside: +4,113.19%
Nov 9, 2022
Maintains: Buy
Price Target: $65 → $55
Current: $8.14
Upside: +575.68%
Aug 16, 2022
Maintains: Neutral
Price Target: $1.25 → $10
Current: $3.88
Upside: +158.06%
Sep 20, 2021
Upgrades: Neutral
Price Target: $100 → $88
Current: $10.43
Upside: +738.93%
Feb 9, 2021
Downgrades: Neutral
Price Target: $0.7 → $13
Current: $1.07
Upside: +1,114.95%